FindTrial
Sign In

A study to classify atopic dermatitis based on serum immunoglobulin E and interleukin levels

A Study on Stratification of Atopic Dermatitis Based on Serum Immunoglobulin E (IgE) and Interleukin Level - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/059864
Enrollment
74
Registered
2023-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Arun V P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Atopic dermatitis patients in the age group of 6 months to 18 years, of both gender.

Exclusion criteria

Exclusion criteria: 1. Patients with other comorbidities are excluded. 2. Patients with parasitic diseases. 3. Patients who are undergoing treatment with steroids and other immunomodulators or suppressants for the last 3 months.

Design outcomes

Primary

MeasureTime frame
Serum immunoglobulin E Serum interleukin 4 Serum interleukin 17Timepoint: 6 months to 18 years—

Secondary

MeasureTime frame
Scoring Atopic Dermatitis (SCORAD) score assessmentTimepoint: 6 months to 18 years—

Countries

India

Contacts

Public ContactArun V P

Amala institute of medical sciences

criton@thecriton.com9447009990

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026